2000
DOI: 10.1002/(sici)1521-3773(20000417)39:8<1449::aid-anie1449>3.0.co;2-a
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of the N-Terminal N-Myristoylated and S-Palmitoylated Undetrigintapeptide of Endothelial NO-Synthase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
10
0
2

Year Published

2001
2001
2022
2022

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 5 publications
1
10
0
2
Order By: Relevance
“…Given their relative ease of synthesis, there is an abundance of examples in the literature of short, myristoylated peptides that have been produced synthetically [125–127] . For example, Waldmann and co‐workers prepared eNOS 1–26 , N‐myristoylated and S‐palmitoylated at two positions using a combination of orthogonal enzyme‐labile, acid‐labile, and noble‐metal‐labile protecting groups in a fragment condensation approach [128] . However, this approach was low yielding (<1 %) and laborious, which led the group to develop a linear solid‐phase approach that made use of the Ellman‐sulfonamide resin linker (Scheme 3 A).…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Given their relative ease of synthesis, there is an abundance of examples in the literature of short, myristoylated peptides that have been produced synthetically [125–127] . For example, Waldmann and co‐workers prepared eNOS 1–26 , N‐myristoylated and S‐palmitoylated at two positions using a combination of orthogonal enzyme‐labile, acid‐labile, and noble‐metal‐labile protecting groups in a fragment condensation approach [128] . However, this approach was low yielding (<1 %) and laborious, which led the group to develop a linear solid‐phase approach that made use of the Ellman‐sulfonamide resin linker (Scheme 3 A).…”
Section: Figurementioning
confidence: 99%
“…[55,123] Waldmann and co-workers prepared eNOS 1-26 ,N -myristoylated and S-palmitoylated at two positions using ac ombination of orthogonal enzyme-labile,a cid-labile,a nd noblemetal-labile protecting groups in af ragment condensation approach. [128] However,t his approach was low yielding (< 1%)a nd laborious,w hich led the group to develop al inear solid-phase approach that made use of the Ellmansulfonamide resin linker (Scheme 3A). [113] Specifically,t he authors expanded upon their solid-phase synthesis of resinbound palmitoylated eNOS 1-16 (1;S cheme 1A), with af inal Fmoc-deprotection and on-resin myristoylation with myristoyl chloride (Myr-Cl) to assemble the full-length resin-bound precursor 28.A fter alkylation of the resin linker (with iodoacetonitrile) and subsequent cleavage,t his strategy provided the target myristoylated and dipalmitoylated eNOS 1-26 peptide 29 in am uch-improved yield of 24 %a fter purification.…”
Section: Synthesis Of Myristoylated Peptides and Proteinsmentioning
confidence: 99%
“…Several solution-phase syntheses of Ras-derived peptides were reported earlier. However, in general, solution phase synthesis is more challenging and time-demanding than the synthesis on solid support. The growing lipidated oligopeptide becomes increasingly insoluble in the reaction medium and causes problems with the subsequent coupling steps and the purification …”
Section: Synthesis Of Lipidated Peptidesmentioning
confidence: 99%
“…The growing lipidated oligopeptide becomes increasingly insoluble in the reaction medium and causes problems with the subsequent coupling steps and the purification. 57 2.2. Solid-Phase Synthesis of Lipidated Peptides.…”
Section: Synthesis Of Lipidated Peptidesmentioning
confidence: 99%
“…farnesyl‐ or geranylgeranyl thioethers) ruling out the use of many established protecting groups. While the introduction of enzyme‐ and noble‐metal‐sensitive protecting groups3 provided efficient solutions to this synthetic problem additional degrees of freedom are urgently required if longer peptides and peptides incorporating amino acids with reactive side‐chain functionalities like NH 2 and SH groups have to be constructed 4. This problem is particularly apparent in the case of our target compound, the maleimido‐modified H‐Ras C‐terminus 1 a (Scheme ).…”
Section: Introductionmentioning
confidence: 99%